Davis Walp
About Davis Walp
Davis Walp is the Founder and CEO with over 25 years of experience in life sciences, professional services, and health information technology.
Founder and CEO Davis Walp
Davis Walp is the Founder and CEO with over 25 years of experience in the life sciences manufacturer, professional services, and health information technology sectors. His extensive career has been marked by executive leadership and general management roles across various healthtech startups, focusing on areas such as precision medicine, real-world evidence (RWE) data analytics, clinical and observational research, and patient engagement.
Davis Walp's Professional Experience
Davis Walp has held key executive roles in several organizations within the health information technology industry. His career includes a leadership stint at Decision Resources Group, where he contributed to health analytics, insights, and consulting services. At Veradigm, he managed research offerings for contract research organizations and pharmaceutical sponsors. Walp also led precision medicine strategy and partnership development at Allscripts and oversaw product and customer strategy, client delivery, and collaborative research solutions at ConvergeHEALTH by Deloitte.
Davis Walp's Career in Life Sciences
Before transitioning into health information technology, Davis Walp accumulated over a decade of experience at major pharmaceutical companies such as Johnson & Johnson, Pfizer, and GlaxoSmithKline. In these roles, he focused on strategic marketing, new product planning, and corporate development, which formed a strong foundation for his later work in healthtech and health information services.
Education and Expertise of Davis Walp
Davis Walp holds an MBA from the William E. Simon Graduate School of Business Administration and the University of Rochester. His academic background equipped him with the necessary skills and knowledge base to excel in strategic management, corporate development, and leadership roles within the dynamic health information technology and life sciences sectors.